Metastatic progression and treatment challenges in EBV-associated pulmonary lymphoepithelioma-like carcinoma: a case report

• by Min Wei, Sumin Wu, Yanbo Wang, Mengyuan Zhu, Xiaofen Pan, Chengming Ke

• June 23, 2026

Dana-Farber Research News 06.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from May 16 - 31.

• by

• June 15, 2026

• 27 min

Severe renal and pancreatic toxicities associated with ipilimumab and nivolumab combination therapy in non-small cell lung cancer: a pharmacovigilance analysis of the FDA adverse event reporting system

• by Jiongrui Cao, Li Peng, Jin Yang, Gang Yin, Ping Ke, Jifa Zhang, Min Su, Yun Gao, Yuehui Zhang

• June 17, 2026

Gilead and Merck’s latest trial success and flop

• by Elaine Chen

• June 9, 2026